Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria

Bei Shi Lee, Nitin P. Kalia, Xin Er F. Jin, Erik J. Hasenoehrl, Michael Berney, Kevin Pethe

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Energy metabolism has recently gained interest as a target space for antibiotic drug development in mycobacteria. Of particular importance is bedaquiline (Sirturo), which kills mycobacteria by inhibiting the F 1 F 0 ATP synthase. Other components of the electron transport chain such as the NADH dehydrogenases (NDH-2 and NdhA) and the terminal respiratory oxidase bc 1 :aa 3 are also susceptible to chemical inhibition. Because antituberculosis drugs are prescribed as part of combination therapies, the interaction between novel drugs targeting energy metabolism and classical first and second line antibiotics must be considered to maximize treatment efficiency. Here, we show that subinhibitory concentration of drugs targeting the F 1 F 0 ATP synthase and the cytochrome bc 1 :aa 3 , as well as energy uncouplers, interfere with the bactericidal potency of isoniazid and moxifloxacin. Isoniazid- and moxifloxacin-induced mycobacterial death correlated with a transient increase in intracellular ATP that was dissipated by co-incubation with energy metabolism inhibitors. Although oxidative phosphorylation is a promising target space for drug development, a better understanding of the link between energy metabolism and antibiotic-induced mycobacterial death is essential to develop potent drug combinations for the treatment of tuberculosis.

Original languageEnglish (US)
Pages (from-to)1936-1943
Number of pages8
JournalJournal of Biological Chemistry
Volume294
Issue number6
DOIs
StatePublished - Jan 1 2019

Fingerprint

Mycobacterium
Energy Metabolism
Anti-Bacterial Agents
Proton-Translocating ATPases
Isoniazid
Drug Delivery Systems
bedaquiline
Pharmaceutical Preparations
NADH Dehydrogenase
Oxidative Phosphorylation
Drug Combinations
Cytochromes
Electron Transport
Oxidoreductases
Tuberculosis
Therapeutics
Adenosine Triphosphate
moxifloxacin

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria. / Lee, Bei Shi; Kalia, Nitin P.; Jin, Xin Er F.; Hasenoehrl, Erik J.; Berney, Michael; Pethe, Kevin.

In: Journal of Biological Chemistry, Vol. 294, No. 6, 01.01.2019, p. 1936-1943.

Research output: Contribution to journalArticle

Lee, Bei Shi ; Kalia, Nitin P. ; Jin, Xin Er F. ; Hasenoehrl, Erik J. ; Berney, Michael ; Pethe, Kevin. / Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria. In: Journal of Biological Chemistry. 2019 ; Vol. 294, No. 6. pp. 1936-1943.
@article{b6c856204dc142a4a0d10ba1854f9216,
title = "Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria",
abstract = "Energy metabolism has recently gained interest as a target space for antibiotic drug development in mycobacteria. Of particular importance is bedaquiline (Sirturo), which kills mycobacteria by inhibiting the F 1 F 0 ATP synthase. Other components of the electron transport chain such as the NADH dehydrogenases (NDH-2 and NdhA) and the terminal respiratory oxidase bc 1 :aa 3 are also susceptible to chemical inhibition. Because antituberculosis drugs are prescribed as part of combination therapies, the interaction between novel drugs targeting energy metabolism and classical first and second line antibiotics must be considered to maximize treatment efficiency. Here, we show that subinhibitory concentration of drugs targeting the F 1 F 0 ATP synthase and the cytochrome bc 1 :aa 3 , as well as energy uncouplers, interfere with the bactericidal potency of isoniazid and moxifloxacin. Isoniazid- and moxifloxacin-induced mycobacterial death correlated with a transient increase in intracellular ATP that was dissipated by co-incubation with energy metabolism inhibitors. Although oxidative phosphorylation is a promising target space for drug development, a better understanding of the link between energy metabolism and antibiotic-induced mycobacterial death is essential to develop potent drug combinations for the treatment of tuberculosis.",
author = "Lee, {Bei Shi} and Kalia, {Nitin P.} and Jin, {Xin Er F.} and Hasenoehrl, {Erik J.} and Michael Berney and Kevin Pethe",
year = "2019",
month = "1",
day = "1",
doi = "10.1074/jbc.RA118.005732",
language = "English (US)",
volume = "294",
pages = "1936--1943",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "6",

}

TY - JOUR

T1 - Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria

AU - Lee, Bei Shi

AU - Kalia, Nitin P.

AU - Jin, Xin Er F.

AU - Hasenoehrl, Erik J.

AU - Berney, Michael

AU - Pethe, Kevin

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Energy metabolism has recently gained interest as a target space for antibiotic drug development in mycobacteria. Of particular importance is bedaquiline (Sirturo), which kills mycobacteria by inhibiting the F 1 F 0 ATP synthase. Other components of the electron transport chain such as the NADH dehydrogenases (NDH-2 and NdhA) and the terminal respiratory oxidase bc 1 :aa 3 are also susceptible to chemical inhibition. Because antituberculosis drugs are prescribed as part of combination therapies, the interaction between novel drugs targeting energy metabolism and classical first and second line antibiotics must be considered to maximize treatment efficiency. Here, we show that subinhibitory concentration of drugs targeting the F 1 F 0 ATP synthase and the cytochrome bc 1 :aa 3 , as well as energy uncouplers, interfere with the bactericidal potency of isoniazid and moxifloxacin. Isoniazid- and moxifloxacin-induced mycobacterial death correlated with a transient increase in intracellular ATP that was dissipated by co-incubation with energy metabolism inhibitors. Although oxidative phosphorylation is a promising target space for drug development, a better understanding of the link between energy metabolism and antibiotic-induced mycobacterial death is essential to develop potent drug combinations for the treatment of tuberculosis.

AB - Energy metabolism has recently gained interest as a target space for antibiotic drug development in mycobacteria. Of particular importance is bedaquiline (Sirturo), which kills mycobacteria by inhibiting the F 1 F 0 ATP synthase. Other components of the electron transport chain such as the NADH dehydrogenases (NDH-2 and NdhA) and the terminal respiratory oxidase bc 1 :aa 3 are also susceptible to chemical inhibition. Because antituberculosis drugs are prescribed as part of combination therapies, the interaction between novel drugs targeting energy metabolism and classical first and second line antibiotics must be considered to maximize treatment efficiency. Here, we show that subinhibitory concentration of drugs targeting the F 1 F 0 ATP synthase and the cytochrome bc 1 :aa 3 , as well as energy uncouplers, interfere with the bactericidal potency of isoniazid and moxifloxacin. Isoniazid- and moxifloxacin-induced mycobacterial death correlated with a transient increase in intracellular ATP that was dissipated by co-incubation with energy metabolism inhibitors. Although oxidative phosphorylation is a promising target space for drug development, a better understanding of the link between energy metabolism and antibiotic-induced mycobacterial death is essential to develop potent drug combinations for the treatment of tuberculosis.

UR - http://www.scopus.com/inward/record.url?scp=85061244989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061244989&partnerID=8YFLogxK

U2 - 10.1074/jbc.RA118.005732

DO - 10.1074/jbc.RA118.005732

M3 - Article

VL - 294

SP - 1936

EP - 1943

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 6

ER -